Asker Healthcare Group AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	492	360	203	430	467
Depreciation & Amortization	816	548	502	341	185
Other Amortization	-	60	46	54	45
Loss (Gain) From Sale of Assets	-	-	1	-	-
Other Operating Activities	13	300	179	118	-108
Change in Accounts Receivable	-87	292	-217	-22	239
Change in Inventory	53	-144	21	-12	-181
Change in Other Net Operating Assets	41	-189	317	67	-265
Operating Cash Flow	1,328	1,227	1,052	976	382
Operating Cash Flow Growth	8.23%	16.63%	7.79%	155.50%	-
Capital Expenditures	-590	-348	-151	-123	-124
Sale of Property, Plant & Equipment	15	-	-	1	-
Cash Acquisitions	-2,331	-1,109	-632	-1,738	-719
Investing Cash Flow	-2,906	-1,457	-783	-1,860	-843
Short-Term Debt Issued	59	-	-	-	-
Long-Term Debt Issued	5,098	593	77	902	858
Total Debt Issued	5,157	593	77	902	858
Long-Term Debt Repaid	-4,548	-296	-219	-734	-235
Net Debt Issued (Repaid)	609	297	-142	168	623
Issuance of Common Stock	1,407	-	63	399	1
Other Financing Activities	9	8	-4	5	-5
Financing Cash Flow	2,025	305	-83	572	619
Foreign Exchange Rate Adjustments	-53	24	-5	29	3
Miscellaneous Cash Flow Adjustments	-	-	-1	-	-
Net Cash Flow	394	99	180	-283	161
Free Cash Flow	738	879	901	853	258
Free Cash Flow Growth	-16.04%	-2.44%	5.63%	230.62%	-
Free Cash Flow Margin	4.40%	5.85%	6.70%	7.28%	2.76%
Free Cash Flow Per Share	1.93	3.34	3.44	3.30	1.09
Cash Interest Paid	201	228	192	95	-
Cash Income Tax Paid	337	201	126	100	85
Levered Free Cash Flow	492.13	478.5	698	400.38	-
Unlevered Free Cash Flow	849.63	667.25	863	516.63	-
Change in Working Capital	7	-41	121	33	-207

Source: S&P Global Market Intelligence. Standard template. Financial Sources.